1. Home
  2. TGS vs IRTC Comparison

TGS vs IRTC Comparison

Compare TGS & IRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Transportadora de Gas del Sur SA TGS

TGS

Transportadora de Gas del Sur SA TGS

HOLD

Current Price

$29.05

Market Cap

4.6B

Sector

Utilities

ML Signal

HOLD

Logo iRhythm Technologies Inc.

IRTC

iRhythm Technologies Inc.

HOLD

Current Price

$123.07

Market Cap

4.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TGS
IRTC
Founded
1992
2006
Country
Argentina
United States
Employees
N/A
N/A
Industry
Natural Gas Distribution
Medical/Dental Instruments
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.6B
4.2B
IPO Year
2002
2016

Fundamental Metrics

Financial Performance
Metric
TGS
IRTC
Price
$29.05
$123.07
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
13
Target Price
$40.00
$197.92
AVG Volume (30 Days)
193.8K
612.7K
Earning Date
05-12-2026
04-30-2026
Dividend Yield
3.01%
N/A
EPS Growth
N/A
61.71
EPS
N/A
N/A
Revenue
N/A
$747,138,000.00
Revenue This Year
$2.13
$19.60
Revenue Next Year
N/A
$15.94
P/E Ratio
$17.56
N/A
Revenue Growth
N/A
26.24
52 Week Low
$19.74
$100.85
52 Week High
$36.35
$210.01

Technical Indicators

Market Signals
Indicator
TGS
IRTC
Relative Strength Index (RSI) 49.29 52.76
Support Level $28.30 $112.26
Resistance Level $32.00 $129.48
Average True Range (ATR) 0.85 5.52
MACD 0.19 -0.33
Stochastic Oscillator 50.48 54.95

Price Performance

Historical Comparison
TGS
IRTC

About TGS Transportadora de Gas del Sur SA TGS

Transportadora de Gas del Sur SA is a natural gas transporter in Latin America. The company's operating segments include Natural Gas Transportation, Midstream, Telecommunications, and Liquids Production and Commercialization. It generates maximum revenue from the Natural Gas Transportation segment. Geographically, it derives the majority of its revenue from Argentina.

About IRTC iRhythm Technologies Inc.

iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.

Share on Social Networks: